Eli Lilly and Company (LLY)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. David A. Ricks | Chairman, CEO & President | 6.29M | -- | 1968 |
Ms. Anat Ashkenazi | Executive VP & CFO | 2.96M | -- | 1973 |
Dr. Daniel M. Skovronsky M.D., Ph.D. | EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology | 3.82M | -- | 1974 |
Ms. Anat Hakim J.D. | Executive VP, General Counsel & Secretary | 2.81M | -- | 1969 |
Mr. Jacob S. Van Naarden | Executive VP & President of Loxo | 2.38M | -- | 1985 |
Mr. Donald A. Zakrowski | Senior VP of Finance & Chief Accounting Officer | -- | -- | -- |
Mr. Diogo Rau | EVP & Chief Information and Digital Officer | 1.06M | -- | 1975 |
Mr. Alonzo Weems | EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer | -- | -- | 1971 |
Mr. Eric Dozier | Executive Vice President of Human Resources & Diversity | -- | -- | 1968 |
Mr. Jeffrey N. Simmons | Senior VP & President of Elanco Animal Health | 1.73M | -- | 1967 |
Eli Lilly and Company
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 43,000
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Corporate Governance
Upcoming Events
June 10, 2024 at 12:00 AM UTC
Dividend Date
August 8, 2024 at 12:30 PM UTC
Eli Lilly and Company Earnings Date
Recent Events
May 15, 2024 at 12:00 AM UTC
Ex-Dividend Date
May 3, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)